8-K current report · filed Aug 3, 2026

Danaher Corporation (DHR) 8-K Current Report: August 3, 2026

Item 5.02Item 7.01Item 8.01Item EX-99.1DHR overview

Short answer

Danaher Corporation (DHR) filed an 8-K current report with the SEC on August 3, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). August 3, 2026 press release announced a leadership transition.

Danaher Corporation 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • August 3, 2026 press release announced a leadership transition
  • Leadership changes may affect strategic execution and management continuity

Item 7.01 · Regulation FD Disclosure

  • Reg FD disclosure includes standard non-filing language for the furnished information
  • Information excluded from Exchange Act Section 18 liability
  • Disclosure not incorporated into other SEC filings unless expressly referenced

Item 8.01 · Other Events

  • Forward-looking disclosure highlights anticipated growth, Long-Term Growth Program benefits, and pending StatLab acquisition
  • StatLab transaction remains subject to customary closing conditions, including regulatory clearances
  • Masimo acquisition debt creates ongoing operational and liquidity exposure
  • Key risks include tariffs, healthcare-market cyclicality, competition, regulation, litigation, cybersecurity, and climate requirements
  • Investors should weigh execution, integration, and regulatory risks against projected acquisition and growth benefits

Item EX-99.1 · Exhibit EX-99.1

  • Julie Sawyer Montgomery becomes CEO and board member October 1, 2026, marking a planned leadership succession
  • Rainer Blair retires October 1 after six years as CEO, remaining senior advisor through March 31, 2027
  • Diagnostics revenue grew from approximately $6.0B in 2017 to approximately $11.0B, with operating profit approximately tripling under Montgomery
  • Special equity incentive awards for key leaders and founders may support retention but create potential dilution
  • Third-quarter and full-year 2026 guidance unchanged, limiting immediate financial implications for investors

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Danaher Corporation 8-K filings

Get the next DHR 8-K as it lands

Follow DHR for push alerts, or ask the research agent what this filing means.